Clinical Trial Update: Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Long-term safety study of vildagliptin in patients with type 2 diabetes has completed Phase 3 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED